Seeing C diff differently

Lancet Gastroenterol Hepatol. 2022 Mar;7(3):207. doi: 10.1016/S2468-1253(22)00014-0.
No abstract available

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Clostridioides difficile
  • Consumer Health Information
  • Cost of Illness
  • Enterocolitis, Pseudomembranous / complications*
  • Enterocolitis, Pseudomembranous / diagnosis
  • Enterocolitis, Pseudomembranous / drug therapy
  • False Negative Reactions
  • Humans
  • Metronidazole / therapeutic use
  • Vancomycin / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Metronidazole
  • Vancomycin